返回 Agenda
Session Chair(s)
Luc Besancon, PHARMD
General secretary and CEO
International Pharmaceutical Federation, Netherlands
Learning Objective : - To understand methods to gain early access to market for innovative therapies, particularly in areas of unmet need - To understand application requirements in the UK, Sweden, Italy, the Netherlands and France to obtain early access to market - To understand the ability to obtain reimbursement for medicinal product supply under early access schemes in EU Member States
Speaker(s)
Early Access Programmes in Europe: Practical Strategies to Accelerate Time to Market
Natalie Thomas, PHD
Clinical Network Services (UK) Ltd, United Kingdom
Consultant
Medicine Shortages: What is the Situation?
Luc Besancon, PHARMD
International Pharmaceutical Federation, Netherlands
General secretary and CEO
Parallel trade – Blessing or curse of the free movement of goods
Susanne Brendler-Schwaab, PHD
BfArM, Germany
Head of Unit, Parallel Import, Parallel Distribution and Standard Marketing